Therapeutic effects of rifampin and erythromycin in experimental murine brucellosis.
Felek
S
S
Department of Clinical Microbiology and Infectious Diseases, Firat Universitesi, Firat Tip Merkezi, 23200 Elazig, Turkey. feleks@yahoo.com
Demirdag
K
K
Kalkan
A
A
Akbulut
A
A
D000818:Animals; D017347:Brucella melitensis / Q000187:drug effects / Q000254:growth & development; D002006:Brucellosis / Q000188:drug therapy*; D004195:Disease Models, Animal; D004917:Erythromycin / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008826:Microbial Sensitivity Tests; D012293:Rifampin / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
D004917:Erythromycin; D012293:Rifampin